Average Co-Inventor Count = 7.36
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Enanta Pharmaceuticals, Inc. (10 from 292 patents)
2. Bristol-myers Squibb Pharma Company (1 from 234 patents)
11 patents:
1. 8236807 - Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
2. 8124584 - Macrocyclic hepatitis C serine protease inhibitors
3. RE42375 - Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
4. 7718769 - Tri-peptide hepatitis C serine protease inhibitors
5. 7601709 - Macrocyclic hepatitis C serine protease inhibitors
6. 7566719 - Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
7. 7368452 - Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
8. 7273851 - Tri-peptide hepatitis C serine protease inhibitors
9. 7176208 - Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors
10. 7125845 - Aza-peptide macrocyclic hepatitis C serine protease inhibitors
11. 6951872 - Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors